What Timeline does

Timeline is a Swiss life sciences company that develops and commercializes Mitopure®, a proprietary >99% pure form of Urolithin A that activates mitophagy — the cellular recycling process responsible for clearing damaged mitochondria. Founded in 2007 by EPFL scientists Chris Rinsch, PhD, and Patrick Aebischer, MD, the company operates through Timeline Longevity Inc. (the US consumer brand headquartered in North Palm Beach, FL) and parent Amazentis SA (the Swiss biotech entity headquartered in Lausanne that holds the IP and runs R&D). Over 18 years, Timeline has invested more than CHF 50 million in research, generating 25+ registered human clinical trials involving 2,000+ participants, results published in Nature Medicine, Nature Metabolism, Cell Reports Medicine, and JAMA, FDA GRAS status obtained through direct agency review, NSF Certified for Sport designation, and 80+ global patents.

Name

Timeline

Legal name

Timeline Longevity Inc

Website

https://timeline.com

Company type

Private

Founded year

2007

Operating status

Operating

Headcount range

51–100 employees

Short description

Timeline is a Swiss longevity biotech that develops and sells Mitopure® (Urolithin A) supplements and skincare via direct-to-consumer channels and a global licensing partnership with Lancôme, targeting health-conscious adults and premium skincare consumers.

Ownership category

akta.pro rank

Product category

Longevity Supplements and Mitochondrial Skincare

NAICS

Toilet Preparation Manufacturing (325620), Food (Health) Supplement Retailers (456191)

SIC

Perfumes, Cosmetics & Other Toilet Preparations (2844), Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Condition-Specific Bioactives (Glucosamine/Chondroitin, Plant Sterols, Melatonin, Lutein/Zeaxanthin) (AFAJAKAK)

akta.pro secondary industries

Treatment Skincare (Serums, Actives, Acne & Anti-aging) (CRABAAAB), Dermocosmetics & Medical-Grade Skincare (CRABAAAF)

Keywords

• Mitochondrial health supplements
• Longevity nutritional products
• Urolithin A dietary supplements
• Cellular health skincare
• Mitophagy activation ingredients

Headquarters

HQ city

Lausanne

HQ country

Switzerland

HQ region

Europe

Offices2 records

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Marketing or Sales, Personnel, Supply Chain, Operations

Revenue model

1. Direct-to-Consumer Supplement Sales: Timeline sells Mitopure supplements (softgels, powder, gummies) directly to consumers via its e-commerce platform (timeline.com), with a subscription-first model offering monthly, 2-month, 4-month, and 12-month delivery plans with progressive discounts (10-30% savings). One-time purchases are also available.
2. Direct-to-Consumer Skincare Sales: Timeline sells a full skincare line (cleanser, exfoliator, serum, moisturizers, eye cream) directly to consumers via its e-commerce platform, with products priced from $55 to $200 per unit. The skincare line is a growing category extension launched in 2023.
3. Ingredient Licensing to Lancôme: Timeline licenses its Mitopure® technology to Lancôme (L'Oréal) for use in the Absolue Longevity MD skincare range, representing the first large-scale deployment of Mitopure at global scale through a major luxury beauty brand. This is a B2B licensing/ingredient supply arrangement.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels8 records

Core offering

Timeline sells Mitopure®-powered nutritional supplements (Gummies, Softgels, Powder) and a topical skincare line (Cleanser, Exfoliator, Firming Serum, Eye Cream, Barrier Cream, Dewy Cream) targeted at mitochondrial health, healthy aging, and cellular energy. All products deliver 500mg of proprietary >99%-pure Urolithin A per serving and are backed by 25+ clinical trials, FDA GRAS status, and 80+ global patents.

Product overview

Timeline is a Swiss longevity biotech company offering a dual-portfolio of Mitopure-powered products centered on its proprietary Urolithin A molecule. The supplement line includes three delivery formats: Mitopure Gummies (sugar-free strawberry gummies), Mitopure Softgels (vegan softgels), and Mitopure Powder (berry-flavored sachets), all providing 500mg of Urolithin A per serving. The skincare line features six topical products: Mitopure Gentle Cleanser, Resurfacing Exfoliator, Firming Serum, Dewy Cream, Barrier Cream, and Eye Cream, all incorporating Mitopure with niacinamide and trehalose for mitochondrial-powered skin longevity. Both product lines are backed by 18+ years of research, 25+ clinical trials, and 80+ global patents, with the technology now expanding into luxury beauty through a global partnership with L'Oréal's Lancôme brand.

Differentiator

Problem solved

Functional benefit

Brands

• Mitopure: Proprietary Urolithin A ingredient and brand used across Timeline's supplement and skincare products

Products and services

• Mitopure Gummies Sugar-free strawberry-flavored gummy supplement delivering 500mg of Urolithin A (Mitopure) per 2-gummy serving. Vegan, HSA/FSA eligible, and clinically proven to improve cellular energy and muscle strength via mitophagy activation. Targeted at adults seeking evidence-based daily mitochondrial support.
• Mitopure Softgels Vegan softgel supplement containing 500mg of Urolithin A (Mitopure) per 2-softgel serving. Tasteless, NSF Certified for Sport, and designed as the simplest, most direct daily Mitopure format for athletes and health-conscious consumers.
• Mitopure Powder Berry-flavored powder supplement in stickpack format delivering 500mg of Urolithin A (Mitopure) per sachet. Sugar-free, NSF Certified for Sport, designed to mix easily into beverages for users who prefer not to take pills or gummies.
• Mitopure Gentle Cleanser Barrier-conditioning facial cleanser priced at $55 (100mL). Formulated as part of the Mitopure skincare line powered by mitochondrial science to support skin cellular energy and resilience.
• Mitopure Resurfacing Exfoliator Rapid-action chemical resurfacing treatment priced at $70 (100mL). Clinically demonstrated to increase skin cell renewal by 2.1x after 15 days; smooths skin texture and enhances radiance.
• Mitopure Firming Serum High-impact skin health treatment serum priced at $200 (30mL). Combines Mitopure with niacinamide and trehalose at efficacious levels for visible firming results.

Quantifiable outcome

• Mitochondrial renewal increases by +39% after 16 weeks over placebo
• +6 more outcomes

Named customers5 records

Segments5 records

Ideal customer profiles6 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Three partnerships are on record, tiered flagship, minor and core.

• Lancôme (L'Oréal)flagshipStrategic or Co-development Partner · 19 February 2026Lancôme entered a landmark global partnership with Timeline to commercialize Mitopure® in a worldwide skincare range — the first large-scale deployment of Mitopure technology through a major luxury beauty brand. The partnership was unveiled in February 2026 and products (Absolue Longevity MD) launched globally at the American Academy of Dermatology Congress in March 2026. The collaboration is backed by L'Oréal's Longevity Integrative Science framework and includes Lancôme's proprietary Cell BioPrint diagnostic technology.
• XPRIZEminorOthers · 4 November 2025Timeline was named a Top 40 Global Finalist in the $101 million XPRIZE Healthspan Competition in 2025, recognizing the company's clinical longevity interventions on a global stage. This recognition validates Timeline's science-first approach and provides additional visibility for the brand.
• EPFL (École Polytechnique Fédérale de Lausanne)coreStrategic or Co-development Partner · 1 January 2007Timeline was founded by scientists from EPFL (Swiss Federal Institute of Technology Lausanne) in 2007. The company's Mitopure technology originated from pioneering research at EPFL, and the institution continues as a research partner. Professor Johan Auwerx (EPFL) and Professor Patrick Aebischer (EPFL President Emeritus) serve as scientific advisors, maintaining an ongoing academic collaboration.

Scale indicators7 records

Recent moves8 records

Expansion highlights6 records

Direct peers

• Elysium Health: Elysium Health is a direct peer: a science-led longevity supplement brand built around proprietary cellular-health ingredients (e.g., NAD-boosting Basis) with subscription DTC, physician endorsement, and clinical-trial-driven marketing, closely mirroring Timeline's playbook.
• ChromaDex (Tru Niagen): ChromaDex sells Niagen (nicotinamide riboside) supplements for cellular energy and mitochondrial health via DTC and retail, making it a direct competitor in the longevity/mitochondrial supplement category.
• Codex Beauty: Codex Beauty is a biotech-meets-skincare brand combining clinically validated bioactives (including Urolithin A) with high-end topical formulations, making it a direct peer in the science-driven dermocosmetics space.
• Allies of Skin: Allies of Skin is a clinical-grade skincare brand leveraging bioactives, encapsulated delivery, and clinical evidence for visible skin longevity outcomes, comparable to Timeline's Mitopure skincare line.
• Dr. Barbara Sturm: Dr. Barbara Sturm is a luxury skincare brand that combines physician-developed science, premium ingredients, and clinical positioning, comparable to Timeline's high-end skincare approach.
• AG1 (Athletic Greens): AG1 is a daily foundational nutrition subscription brand with strong DTC, celebrity/athlete endorsements, and a premium recurring-revenue model, making it a comparable premium supplement peer.
• Life Extension: Life Extension is a long-established science-led supplement brand offering clinically validated longevity and cellular-health formulations, directly comparable to Timeline's evidence-based approach.

Emerging players

• Novos: Novos is an emerging longevity supplement brand formulating multiple cellular-health ingredients (including Urolithin A) targeting healthspan, with a science- and evidence-driven positioning directly comparable to Timeline.

Broad incumbents

• Nestlé Health Science: Nestlé Health Science is both an investor and a broad incumbent in clinical nutrition, functional food, and supplement ingredients, providing both a strategic benchmark and channel/distribution upside for Timeline.
• L'Oréal (Lancôme): L'Oréal is both an investor and the parent of Lancôme, which embeds Mitopure globally; as a broad incumbent it provides distribution, formulation, and prestige-marketing context comparable to how Timeline's ingredient competes inside a major luxury beauty portfolio.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• TikToktiktok.com/@timeline
• Xx.com/Amazentis1
• Facebookfacebook.com/TimelineNutrition
• LinkedInlinkedin.com/company/amazentis-sa

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds5 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Timeline